Obstetric anesthesia

Commonly used antiemetics for prophylaxis of postoperative nausea and vomiting after Caesarean delivery with neuraxial morphine: a network meta-analysis

Br J AnaesthPublished Systematic review and network meta-analysis of randomised controlled trials

Authors' conclusion

Combined 5-HT3 antagonists plus dexamethasone are more effective than monotherapy in preventing PONV associated with neuraxial morphine after Caesarean delivery.

Study context

Population
Women receiving neuraxial morphine for Caesarean delivery
Participants
4,238 women · 33 studies
Comparison
5-HT3 antagonists, dopamine antagonists, dexamethasone, and 5-HT3 antagonists plus dexamethasone vs placebo
Outcome
Incidences of postoperative nausea (PON) and postoperative vomiting (POV)
Follow-up
Within 24 h after surgery
Methodological detailsBayesian random-effects model, sensitivity and subgroup analyses, Most included studies had some concerns or a high risk of bias
  • Bayesian random-effects model
  • Sensitivity and subgroup analyses
  • Most included studies had some concerns or a high risk of bias

Pooled result

As reported in the abstract

PON and POV, all women
  • 5-HT3 antagonists, dopamine antagonists, dexamethasone, and 5-HT3 antagonists plus dexamethasone significantly reduced postoperative nausea (PON) and postoperative vomiting (POV) vs placebo
  • 5-HT3 antagonists plus dexamethasone more effective than monotherapy
  • ORs with 95% CrI
  • Overall certainty of evidence low or very low

Further pooled results

PON and POV by neuraxial opioid (subgroup)

Similar results in women receiving epidural morphine or intrathecal morphine alone, but not intrathecal morphine with fentanyl or sufentanil

Original publication

Commonly used antiemetics for prophylaxis of postoperative nausea and vomiting after Caesarean delivery with neuraxial morphine: a network meta-analysis. Br J Anaesth. Published 15 April 2024. doi:10.1016/j.bja.2024.03.010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.